High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes

被引:203
作者
Smith, IL
Cherrington, JM
Jiles, RE
Fuller, MD
Freeman, WR
Spector, SA
机构
[1] UNIV CALIF SAN DIEGO, DEPT PEDIAT, CTR MOL GENET, LA JOLLA, CA 92093 USA
[2] UNIV CALIF SAN DIEGO, DEPT OPHTHALMOL, CTR MOL GENET, LA JOLLA, CA 92093 USA
[3] GILEAD SCI INC, FOSTER CITY, CA 94404 USA
[4] UNIV CALIF SAN DIEGO, CTR AIDS RES, LA JOLLA, CA 92093 USA
关键词
D O I
10.1086/514041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mutations in both the viral phosphotransferase gene, UL97, and the DNA polymerase gene, UL54, have been shown to confer ganciclovir resistance to cytomegalovirus (CMV), Moreover, UL54 alterations have been associated with in vitro cross-resistance of CMV to cidofovir, To investigate the relative significance of UL97 versus UL54 alterations in conferring antiviral resistance, phenotypic and genotypic characterization of 28 ganciclovir-resistant clinical CMV isolates was undertaken, Isolates were either low-level ganciclovir-resistant, which have ganciclovir ID50 values greater than or equal to 8 mu M and <30 mu M and sensitivity to cidofovir, or high-level ganciclovir-resistant, which have ganciclovir ID50 values greater than or equal to 30 mu M and cross-resistance to cidofovir, Low-level ganciclovir-resistant isolates were associated with UL97 alterations and short periods of ganciclovir treatment, while high-level ganciclovir-resistant isolates were associated with both UL97 and polymerase alterations and were cultured after extended ganciclovir therapy.
引用
收藏
页码:69 / 77
页数:9
相关论文
共 34 条
  • [1] Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS
    Baldanti, F
    Underwood, MR
    Stanat, SC
    Biron, KK
    Chou, SW
    Sarasini, A
    Silini, E
    Gerna, G
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (03) : 1390 - 1395
  • [2] A 3-NUCLEOTIDE DELETION IN THE UL97 OPEN READING FRAME IS RESPONSIBLE FOR THE GANCICLOVIR RESISTANCE OF A HUMAN CYTOMEGALOVIRUS CLINICAL ISOLATE
    BALDANTI, F
    SILINI, E
    SARASINI, A
    TALARICO, CL
    STANAT, SC
    BIRON, KK
    FURIONE, M
    BONO, F
    PALU, G
    GERNA, G
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (02) : 796 - 800
  • [3] Baldanti F, 1995, SCAND J INFECT DIS, P103
  • [4] Susceptibility of human cytomegalovirus to cidofovir is unchanged after limited in vivo exposure to various clinical regimens of drug
    Cherrington, JM
    Miner, R
    Hitchcock, MJM
    Lalezari, JP
    Drew, WL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (04) : 987 - 992
  • [5] CHERRINGTON JM, 1995, 35 INT C ANT AG CHEM
  • [6] FREQUENCY OF UL97 PHOSPHOTRANSFERASE MUTATIONS RELATED TO GANCICLOVIR RESISTANCE IN CLINICAL CYTOMEGALOVIRUS ISOLATES
    CHOU, SW
    GUENTZEL, S
    MICHELS, KR
    MINER, RC
    DREW, WL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01) : 239 - 242
  • [7] ANALYSIS OF THE UL97 PHOSPHOTRANSFERASE CODING SEQUENCE IN CLINICAL CYTOMEGALOVIRUS ISOLATES AND IDENTIFICATION OF MUTATIONS CONFERRING GANCICLOVIR RESISTANCE
    CHOU, SW
    ERICE, A
    JORDAN, MC
    VERCELLOTTI, GM
    MICHELS, KR
    TALARICO, CL
    STANAT, SC
    BIRON, KK
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) : 576 - 583
  • [8] CRUMPAKCER CSE, 1996, J ACQUIR IMMUNE D S1, V12, P6
  • [9] PREVALENCE OF RESISTANCE IN PATIENTS RECEIVING GANCICLOVIR FOR SERIOUS CYTOMEGALOVIRUS-INFECTION
    DREW, WL
    MINER, RC
    BUSCH, DF
    FOLLANSBEE, SE
    GULLETT, J
    MEHALKO, SG
    GORDON, SM
    OWEN, WF
    MATTHEWS, TR
    BUHLES, WC
    DEARMOND, B
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) : 716 - 719
  • [10] PROGRESSIVE DISEASE DUE TO GANCICLOVIR-RESISTANT CYTOMEGALO-VIRUS IN IMMUNOCOMPROMISED PATIENTS
    ERICE, A
    CHOU, S
    BIRON, KK
    STANAT, SC
    BALFOUR, HH
    JORDAN, MC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) : 289 - 293